Lehman Brothers “One Hundred Percent Protected” PPN

The Meissner firm investigating potential claims by investors who were recommended the unsuitable sale by Securities America broker Randall Ray Talbott and other of Medical Capital Holdings
The Meissner Firm Investigating Bank of America Structured Products
Lehman Brothers “One Hundred Percent Protected” Principal Protected Notes (PPN)
The Morgan Keegan Bond Funds
Rhonda Breard and ING Financial
Wells Fargo Financial Investments and Sale of Market Linked Certificates of Deposits
Collateralized Debt Obligation Investigation
Provident Royalties Fraud/Ponzi Scheme
Citigroup’s ASTA and MAT Funds:
Oppenheimer Champion Income Fund:
Oppenheimer Core Bond Fund
The Aravali Fund
Preferred Financial Stocks
Td Ameritrade Reserve Yield Plus Fund
Shay Financial Services, Inc
ABACUS and Goldman Sachs

The sale of PPN’s as combining the purported safety of bonds with a potential for growth which are not available in other fixed income products. Such products are not free of risk and the terms are complex. In December 2009 FINRA issued a regulatory notice reminding brokerage firms of sales practice obligations not to overstate either the protection offered or the potential returns. FINRA requires numerous disclosures related to the sale of such instruments and as with all securities a proper suitability review before recommending PPN’s. The sale of Lehman Brothers Principal Protected Notes to investors by UBS and other firms, while emphasizing that the principal was guaranteed to be protected have been the focus of multiple investor claims which have led to significant investor awards. If you were misled by the sale of  PPN’a by UBS or any other brokerage firm contact the Meissner firm, which is nationally known for its record win statistics in arbitration, for a free consultation.